Management of Uncontrolled Blood Sugar in Type 2 Diabetes
Initial Assessment and Treatment Strategy
- The American Diabetes Association recommends a stepwise approach starting with metformin as first-line therapy, followed by rapid addition of medications when glycemic targets are not achieved, and early initiation of insulin therapy for severely uncontrolled cases 1, 2
- Lifestyle interventions including diet modifications and physical activity should be implemented and maintained throughout the course of diabetes management, but should not delay pharmacological intervention 1, 3
- Metformin should be initiated concurrently with lifestyle interventions at diagnosis, unless contraindicated 1, 2
- A patient-centered approach should guide the choice of additional pharmacologic agents based on efficacy, hypoglycemia risk, effect on weight, cost, side effects, and patient preferences 2, 4
Management Based on Severity of Hyperglycemia
- For severely uncontrolled diabetes, insulin therapy combined with lifestyle intervention is the treatment of choice for patients with high blood sugar levels, presence of ketonuria, or symptomatic diabetes 1, 5
- Insulin can be titrated rapidly and provides the greatest likelihood of quickly returning glucose levels to target 1
- For patients with moderately uncontrolled diabetes, consider initiating basal insulin while starting metformin 6
- For patients with mild to moderate hyperglycemia, metformin is the initial pharmacologic treatment of choice if renal function is normal 6, 2
Combination Therapy Approach
- When adding second antihyperglycemic medications, consider drugs with different mechanisms of action for greatest synergy 1
- Insulin plus metformin is particularly effective for lowering glycemia while limiting weight gain 1, 2
- For patients with established cardiovascular disease, chronic kidney disease, or heart failure, a sodium-glucose cotransporter 2 inhibitor or glucagon-like peptide 1 receptor agonist with demonstrated cardiovascular benefit is recommended as part of the glucose-lowering regimen 2, 7
Treatment Intensification
- Treatment intensification for patients not meeting glycemic targets should not be delayed 2, 7
- The medication regimen should be reevaluated at regular intervals (every 3-6 months) and adjusted as needed 2, 7
- For patients treated with basal insulin who do not meet glycemic targets, consider advancing to multiple daily injections with basal and premeal bolus insulins 6
Special Considerations
- For patients with hypoglycemia concerns, consider medications with lower risk of hypoglycemia 1, 3
- For patients where weight management is a priority, consider agents that promote weight loss (e.g., GLP-1 receptor agonists) 1, 3
- In youth with type 2 diabetes, a reasonable HbA1c target when treated with oral agents alone is <7%, with more stringent targets (<6.5%) appropriate for selected patients if achievable without significant hypoglycemia 6